New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
08:02 EDTBDXBecton Dickinson acquires Alverix for $40M
BD announced that it has acquired Alverix, a privately-held diagnostic instrument company known for its optoelectronics expertise. Since 2008, BD and Alverix have collaborated in the point-of-care diagnostic market with the design and development of the BD Veritor System, which has been very well received in hospitals, laboratories, physician offices and clinics. Alverix, headquartered in San Jose, California, is a key supplier to BD Diagnostics' point-of-care instrument platform. BD acquired Alverix for $40M. The transaction is expected to be minimally dilutive for FY14 and will not impact BD's previously communicated 2014 earnings guidance.
News For BDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
15:46 EDTBDXRetractable Technologies reports recognition of payment from Becton, Dickinson
Retractable Technologies (RVP) reports that in the second quarter, RTI will record as income and remove from RTIís current liabilities, the $7,724,826 judgment amount previously paid by Becton, Dickinson and Company (BDX) for damages awarded as a result of BDís infringement of RTIís patents. This patent infringement case and related appeals have concluded. The patent claims were severed from RTIís other claims against BD in 2008. The other portion of the case in which the District Court granted RTI a final judgment for $352M plus other relief is not directly affected by the conclusion of the patent case and the related recognition of the judgment amount.
May 13, 2015
08:07 EDTBDXBecton Dickinson receives FDA clearance for insulin infusion set
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use